Rapid Screening of Cognitive Change in Patients with Questionable Dementia Using the Memory Impairment Screen and the Isaacs Set Test

Chopard, Gilles; Vanholsbeeck, Geraldine; Tio, Grégory; Pitard, Alexandre; Binetruy, Mickael; Rumbach, L.; Galmiche, Jean

doi:10.1111/j.1532-5415.2008.02170.x

Cited by 12 publications

(6 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The mental control subtest of the Wechsler Memory Scale combined with RAVLT delayed recall was shown to have a classification accuracy of 89% in memory-impaired non-demented patients, two years before AD diagnosis [30]. Similarly, high predictive accuracy was found when combining episodic memory with naming [38,39] or verbal fluency [27,40,41]. Particularly high prediction values were obtained when combin-ing memory with more than one other domain.…”

Section: Cognition In Preclinical Admentioning

confidence: 96%

Detecting Early Preclinical Alzheimer's Disease via Cognition, Neuropsychiatry, and Neuroimaging: Qualitative Review and Recommendations for Testing

Belleville

Fouquet

Duchesne

et al. 2014

JAD

View full text Add to dashboard Cite

In this paper, we review studies that have investigated whether neuropsychological, neuropsychiatric, and neuroimaging measures predict decline to Alzheimer's disease (AD). Prospective neuropsychological studies indicate that cognitive performance may be an excellent indicator of future progression from mild cognitive impairment (MCI) to AD, particularly when episodic memory is combined with tasks relying on executive control and language tasks. Research on neuropsychiatric symptoms reveal that depression, apathy, anxiety, and sleep disturbances can contribute to predictive models, though their sensitivity is typically lower than that found with cognitive measures. Finally, different structural brain imaging markers reveal excellent predictive accuracy. The paper discusses issues that will have to be addressed in future studies. First, it will be necessary to increase the evaluation of combined markers, as this may considerably improve predictive accuracy. Second, it will be necessary to move to earlier stages than MCI in order to expand the detection window. Third, processes of compensation and plasticity will have to be better investigated as research moves into earlier stages. The Consortium for the early identification of AD-Quebec (CIMA-Q) is presented as an instance of this approach, and potential batteries of measures are proposed.

show abstract

Section: Cognition In Preclinical Admentioning

confidence: 96%

Detecting Early Preclinical Alzheimer's Disease via Cognition, Neuropsychiatry, and Neuroimaging: Qualitative Review and Recommendations for Testing

Belleville

Fouquet

Duchesne

et al. 2014

JAD

View full text Add to dashboard Cite

show abstract

“…Using the discrete Cox proportional hazards model, Dartiques et al (1997) found the IST to be a better test to predict the development of dementia when compared with the MMSE and BVRT. Chopard et al (2009) found that combining the IST and the MIS resulted in an AUC of 0.86 which was superior to the MMSE (AUC = 0.59). Tang-Wai et al (2003) determined the STMS to be significantly better than the MMSE in discriminating between the four different diagnostic groups in the study.…”

Section: Resultsmentioning

confidence: 99%

“…The majority of answers to the QUADAS items were "yes", and nine studies obtained perfect scores. Three studies (Chopard et al, 2009 ;Larner, 2007 ;Tsukamoto et al, 2009 ) had answers of "no" to one or two of the items. Questions 3 to 11 of the QUADAS tool referred to an index test and reference standard.…”

Section: Methodological Quality Of Included Studiesmentioning

confidence: 99%

“…Five out of the 12 studies in this review reported participant losses at follow-up. Chopard et al ( 2009 ), Tierney et al ( 2000 ), and Lam et al ( 2008 ) lost a high percentage of participants (59 % , 40 % , and 55 % respectively). The remaining two studies reported a smaller percentage of participant losses (Dartiques et al [ 1997] lost 3 % , and Srikanth et al [ 2006] lost 28 % ).…”

Section: Factors Infl Uencing Study Outcomesmentioning

confidence: 99%

See 1 more Smart Citation

A Systematic Review of Screening Tools for Predicting the Development of Dementia

et al. 2012

View full text Add to dashboard Cite

Early detection of dementia is essential to guide front-line health care practitioners in further clinical evaluations and treatments. There is a paucity of literature assessing the effectiveness of screening tools to predict the development of dementia, thus we conducted a systematic review to fill this gap. The purpose of the systematic review was to make recommendations to health care practitioners on which screening tool best predicts the development of dementia and is most feasible in the primary care setting. Ten databases were searched for relevant articles, yielding 751 papers. Of these, 12 met relevance criteria for inclusion. Screening tools were assessed for test accuracy, cognitive domain coverage, predictive ability, and feasibility. Four screening tools were recommended. Addenbrooke's Cognitive Examination (ACE) was considered to be the ideal tool. A revised version of this tool is now used in clinical practice but the psychometric properties of the ACE-R remain to be established.

show abstract

“…El "Memory Impairment Scren" (MIS) (Buschke et al, 1999) es un test que permite evaluar la memoria episódica verbal (recuerdo libre y facilitado de una lista de 4 palabras que el sujeto puede leer) por su contenido viene a ser una prueba muy rápida con una duración de 4-5 minutos (Böhm et al, 2003;Buschke et al, 1999), y pudiéndose aplicar a cualquier tipo de demencia (Chopard et al, 2009). En el caso de la versión española, los autores proponen al MIS como una prueba fiable para diferenciar entre sujetos con demencia Alzheimer, obteniendo índices diagnósticos adecuados (S=0.86 y E=0.96; aROC= 978) y apto como primer instrumento de detección (Böhm et al, 2005).…”

Section: "Memory Impairment Scren" (Mis)unclassified

Estudio preliminar del cogval-senior, una nueva prueba informatizada para la detección de la demencia Alzheimer en personas mayores

Rodríguez¹

View full text Add to dashboard Cite

Índice de Tablas y Figuras Capítulo I Introducción Envejecimiento y Cognición Capítulo II Marco teórico 2.1 La detección temprana del deterioro cognitivo y la demencia 2.2 Característica de una prueba de valoración cognitiva breve 2.3 Pruebas rápidas de cribado cognitivo, en papel y lápiz 2.3.1 Mini-Mental State Examination (MMSE) y Mini-Examen Cognoscitivo (MEC) 2.3.2 El test de Pfeiffer 2.3.3 Test Mental Abreviado 2.3.4 El Test del Reloj 2.3.5 Memory Impairment Scren (MIS) 2.3.6 Test de las Fotos (TdF) 2.3.7 Test de los 7 minutos (T7M) 2.3.8 Prueba Cognitiva Leganés (PCL) 2.3.9 El MoCa 2.3.10 El Eurotest 2.3.11 El TYM 2.3.12 Neuropsi 2.3.13 Addenbrooke's Cognitive Examination (ACE) 2.4 Las nuevas tecnologías en la evaluación neuropsicológica 2.4.1 Ventajas de las nuevas tecnologías en la evaluación cognitiva 2.4.2 Limitaciones técnicas de las nuevas tecnologías en la evaluación 9 cognitiva 2.4.3Pruebas de cribado cognitivo informatizadas 81 2.4.3.1 Kana Pick-out Test 82 2.4.3.2 Hasegawa Dementia Scale 85 2.4.3.3 MSP-1000 87 2.4.3.4 Automated Neuropsychological Assessment Metrics (ANAM) 89 2.4.3.5 Computer-Administered Neuropsychological Screen for Mild Cognitive Impairment 90 2.4.3.6Cambridge Neuropsychological Test Automated Battery 91 2.4.3.7 CNS Signos Vitales (CNS Vital Signs) 92 2.4.3.8 Computerized Neuropsychological Test Battery 94 2.4.3.9 Cognitive Drug Research Computerized Assessment System 95 2.4.3.10 CogState 97 2.4.3.11 Cognitive Stability Index 99 2.4.3.12 MCI Screen 2.4.3.13 MicroCog 2.4.3.14 Mindstreams (Neurotrax) 2.4.3.15 Computer Assessment of Mild Cognitive Impairment 2.4.3.16 NexAde 2.4.3.17 Computerized Dementia Screening Test (CDST)

show abstract

Rapid Screening of Cognitive Change in Patients with Questionable Dementia Using the Memory Impairment Screen and the Isaacs Set Test

Abstract: This quickly performed tool (5 minutes) is simple to use and score. When including cutscores (MIS<6 or IST<25) or range values, this test could be considered a useful screening procedure for all types of dementias.

Cited by 12 publications

References 26 publications

Detecting Early Preclinical Alzheimer's Disease via Cognition, Neuropsychiatry, and Neuroimaging: Qualitative Review and Recommendations for Testing

Detecting Early Preclinical Alzheimer's Disease via Cognition, Neuropsychiatry, and Neuroimaging: Qualitative Review and Recommendations for Testing

A Systematic Review of Screening Tools for Predicting the Development of Dementia

Estudio preliminar del cogval-senior, una nueva prueba informatizada para la detección de la demencia Alzheimer en personas mayores

Contact Info

Product

Resources

About